H K Breddin1. Show Affiliations » 1. Department of Internal Medicine, J. W. Goethe-University, Frankfurt/Main, FRG.
Abstract
Entities: Disease
Mesh： See more » AnimalsClinical Trials as TopicDrug Evaluation, PreclinicalFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHemorrhage/chemically inducedHeparin/toxicityHeparin, Low-Molecular-Weight/adverse effectsHeparin, Low-Molecular-Weight/therapeutic useHeparin, Low-Molecular-Weight/toxicityHeparinoids/adverse effectsHeparinoids/therapeutic useHumansRabbitsRatsThrombophlebitis/prevention & control
Substances： See more » Fibrinolytic AgentsHeparin, Low-Molecular-WeightHeparinoidsHeparin
Year: 1989 PMID： 2479104 DOI： 10.1055/s-2007-1002738
Source DB: PubMed Journal: Semin Thromb Hemost ISSN： 0094-6176 Impact factor: 4.180